Skip to content
Clinical Trials – home
Stichting Radboud universitair medisch centrum
Sponsor

Stichting Radboud universitair medisch centrum

The Netherlands Geert Grooteplein Zuid 10, 6525 GA Nijmegen, The Netherlands

About the sponsor

Radboud universitair medisch centrum Stichting supports research in a broad range of cancer types, including prostate cancer, breast cancer, ovarian cancer, glioblastoma, non-small cell lung cancer, rectal cancer, and renal cell carcinoma. Its portfolio also includes hematologic malignancies such as chronic myeloid leukaemia, myelodysplastic syndromes, and acute myeloid leukemia.

  • Prostate cancer and castration-resistant prostate cancer
  • Thoracic, gastrointestinal, and urologic malignancies
  • Hematologic cancer and cellular immunotherapy
  • PET/CT imaging and tumor-targeted diagnostics

The sponsor’s oncology research also extends to precision imaging and immune-based treatment strategies in both solid tumors and blood cancers.

About Specializations

Stichting Radboud universitair medisch centrum runs clinical trials in conditions such as Drug use disorder, Type 1 diabetes mellitus, Parkinson's disease, Inflammation, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

71 clinical trials

Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Modafinil
  • Sponsor:Stichting Radboud universitair medisch centrum

Diabetic foot

Recruiting
Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Semaglutide
  • Sponsor:Stichting Radboud universitair medisch centrum
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Colchicine
  • Sponsor:Stichting Radboud universitair medisch centrum
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Atomoxetine
  • Sponsor:Stichting Radboud universitair medisch centrum
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · Healthy volunteers
  • Substances:Hydrocortisone
  • Sponsor:Stichting Radboud universitair medisch centrum
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Rituximab
  • Sponsor:Stichting Radboud universitair medisch centrum
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Biotin
  • Sponsor:Stichting Radboud universitair medisch centrum
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Gozetotide
  • Sponsor:Stichting Radboud universitair medisch centrum
Countries:The NetherlandsThe Netherlands
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:LYSERGIDE
  • Sponsor:Stichting Radboud universitair medisch centrum
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Domperidone
  • Sponsor:Stichting Radboud universitair medisch centrum
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Dextran 70
  • Sponsor:Stichting Radboud universitair medisch centrum
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Ravulizumab
  • Sponsor:Stichting Radboud universitair medisch centrum

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).